IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 41 - 60 of 1180 stories.
October 30, 2014
Cambrex (East Rutherford, NJ) reports a more than doubling in net profits for the third quarter of 2014 compared with the third quarter of 2013, to $8.76 million. Third-quarter sales...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-reports-rise-in-profits_64932.html
October 28, 2014
Feature: API firms eye more investments, acquisitions Pharmaceutical ingredient manufacturers from various parts of the world, interviewed by CW during the CPhI trade fair held in...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-28-October-2014_64843.html
October 27, 2014
Biopharmaceuticals group CSL (Parkville, Australia) announced today that it has agreed to acquire Novartis’s global influenza vaccine business for $275 million. The business will...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/CSL-to-buy-Novartiss-flu-vaccines-business-creating-a-global-leader_64806.html
October 24, 2014
Hikma Pharmaceuticals (London) says it received a warning letter from the FDA on Thursday concerning its plant in Portugal. This letter follows an inspection of the facility in March...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FDA-issues-warning-letter-for-Hikma-Pharmaceuticals-plant-in-Portugal_64779.html
October 24, 2014
Siegfried (Zofingen, Switzerland), a producer of active pharmaceutical ingredients (APIs), pharma intermediates, and finished drugs, says that it has received operating approval from...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Siegfried-API-plant-at-Nantong-receives-operating-approval_64781.html
October 21, 2014
AbbVie and Shire terminate $51-billion deal Shire (Dublin) says that its board has agreed with AbbVie (Chicago) to terminate their previously announced agreement for the acquisition of...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-21-October-2014_64641.html
October 14, 2014
Feature: Positive outlook for API manufacturing industry Active pharmaceutical ingredient (API) manufacturers say that outsourcing of API manufacturing continues to rise and the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-14-October-2014_64490.html
October 8, 2014
Drugs major Cipla (Mumbai) has signed an agreement with its Iranian distributor to establish a manufacturing facility in Iran. The company has informed the Bombay Stock Exchange that...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cipla-to-establish-manufacturing-unit-in-Iran_64276.html
October 8, 2014
BASF announced today that it is teaming up with Colorcon (Harleysville, PA) to release a coating polymer, Kollicoat IR, for Colorcon’s formulated ready-to-use coatings...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/BASF-collaborates-with-Colorcon-on-pharma-coatings_64338.html
October 3, 2014
Sagent Pharmaceuticals (Schaumburg, IL), a leader in specialty pharma products with a focus on the injectable market, has acquired Omega Laboratories (Montreal), a market-leading...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Sagent-Pharmaceuticals-buys-Omega-Laboratories_64253.html
October 3, 2014
Salix Pharmaceuticals (Raleigh, NC) and Cosmo Pharmaceuticals (Lainate, Italy) said on Thursday that they have agreed to terminate their previously announced agreement under which...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharma-merger-cancelled-as-Obama-Administration-tightens-tax-loophole_64252.html
October 2, 2014
Bayer, which has just closed the acquisition of Merck & Co.’s OTC business, today announced that it is issuing a jumbo bond in 144A/Reg S format with a volume of $7 billion...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Bayer-launches-$7-billion-bond-to-finance-Merck-and-Co-OTC-acquisition_64223.html
October 1, 2014
Johnson & Johnson, the biggest maker of consumer health products, has announced a definitive agreement to acquire Alios BioPharma (South San Francisco, CA), a privately held...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Johnson-and-Johnson-to-acquire-Alios-BioPharma-for-$1-75-billion_64182.html
September 30, 2014
Pharmaceutical companies Strides Arcolab (Bangalore, India) and Shasun Pharmaceuticals (Chennai, India) have announced their plans to merge. The boards of directors of the two...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/API-manufacturer-Shasun-announces-merger-with-Strides-Arcolab_64146.html
September 30, 2014
Private equity firm Silverfleet Capital (London) says that it has agreed to sell its portfolio company Aesica Pharmaceuticals (Newcastle-upon-Tyne, UK) to health-care firm Consort...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Consort-Medical-to-acquire-Aesica-for-$372-million_64142.html
September 30, 2014
Consort Medical to acquire Aesica for $372 million Private equity firm Silverfleet Capital (London) says that it has agreed to sell its portfolio company Aesica Pharmaceuticals...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-30-September-2014_64147.html
September 23, 2014
Merck KGaA to acquire Sigma-Aldrich for $17 billion Merck KGaA (Darmstadt, Germany) says it has entered into a definitive agreement to acquire Sigma-Aldrich (St. Louis) for $17...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-23-September-2014_63943.html
September 22, 2014
Merck KGaA (Darmstadt, Germany) says its biopharmaceutical division is well on track with implementing the group’s Fit for 2018 transformation and growth program. At an analysts'...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Merck-KGaA-steps-up-investment-in-biosimilar-activities_63913.html
September 17, 2014
Merck KGaA today declined to comment on a report in The Economic Times of India that it is close to signing a deal, worth $1.5 billion, with India’s pharma major Lupin (Mumbai)...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lupin-to-manufacture-Merck-Serono-drugs-under-$1-5-billion-deal_63820.html
Pages: « Previous  1 2 [3] 4 5 6 7 8 9 10 11 12 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa